Alfredo Csibi Selected Research

Eukaryotic Initiation Factor-3

2/2009	MAFbx/Atrogin-1 controls the activity of the initiation factor eIF3-f in skeletal muscle atrophy by targeting multiple C-terminal lysines.
6/2008	eIF3-f function in skeletal muscles: to stand at the crossroads of atrophy and hypertrophy.
4/2008	The initiation factor eIF3-f is a major target for atrogin1/MAFbx function in skeletal muscle atrophy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alfredo Csibi Research Topics

Disease

9	Neoplasms (Cancer) 01/2018 - 04/2008
5	Muscular Atrophy (Muscle Atrophy) 10/2013 - 04/2008
4	Hypertrophy 10/2013 - 04/2008
3	Tuberous Sclerosis (Bourneville's Disease) 01/2015 - 10/2011
3	Atrophy 02/2009 - 04/2008
2	Prostatic Neoplasms (Prostate Cancer) 01/2019 - 07/2013
2	Lymphangioleiomyomatosis (Lymphangiomyomatosis) 01/2015 - 01/2014
2	Acquired Immunodeficiency Syndrome (AIDS) 06/2008 - 04/2008
1	Neoplasm Metastasis (Metastasis) 01/2019
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2015
1	Respiratory Insufficiency (Respiratory Failure) 01/2014
1	Carcinogenesis 01/2014
1	Starvation 10/2013
1	Genomic Instability 04/2013
1	Insulin Resistance 04/2010
1	Renal Insufficiency (Renal Failure) 06/2008
1	Sepsis (Septicemia) 04/2008

Drug/Important Bio-Agent (IBA)

6	Mechanistic Target of Rapamycin Complex 1IBA 01/2015 - 02/2010
3	Proteins (Proteins, Gene)FDA Link 10/2013 - 04/2008
3	Eukaryotic Initiation Factor-3IBA 02/2009 - 04/2008
2	trans-sodium crocetinate (crocetin)IBA 01/2015 - 10/2011
2	Glutamine (L-Glutamine)FDA Link 07/2013 - 04/2013
2	Glucose (Dextrose)FDA LinkGeneric 07/2013 - 10/2011
2	Peptide Initiation Factors (Initiation Factor)IBA 02/2009 - 04/2008
2	Proteasome Endopeptidase Complex (Proteasome)IBA 02/2009 - 04/2008
2	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 06/2008 - 04/2008
1	Fatty Acid Synthases (Fatty Acid Synthase)IBA 01/2019
1	abirateroneIBA 01/2019
1	enzalutamideIBA 01/2019
1	EnzymesIBA 01/2019
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2019
1	Androgen Receptors (Androgen Receptor)IBA 01/2019
1	H3B-8800IBA 01/2018
1	GlutaminaseIBA 01/2015
1	Therapeutic UsesIBA 01/2015
1	TOR Serine-Threonine KinasesIBA 10/2014
1	Celecoxib (Celebrex)FDA Link 01/2014
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2014
1	lipoarabinomannan (LAM)IBA 01/2014
1	ProstaglandinsIBA 01/2014
1	Estradiol (Delestrogen)FDA LinkGeneric 01/2014
1	Mechanistic Target of Rapamycin Complex 2IBA 01/2014
1	Biological ProductsIBA 10/2013
1	Metformin (Glucophage)FDA LinkGeneric 07/2013
1	Angiotensin IIIBA 04/2010
1	Insulin (Novolin)FDA Link 04/2010
1	Phosphotransferases (Kinase)IBA 02/2010
1	Ligases (Synthetase)IBA 01/2009
1	RNA (Ribonucleic Acid)IBA 01/2009
1	UbiquitinIBA 01/2009
1	Muscle Proteins (Muscle Protein)IBA 06/2008
1	Small Interfering RNA (siRNA)IBA 04/2008

Therapy/Procedure

1	Castration 01/2019
1	Therapeutics 10/2011